dipyridamole has been researched along with vinpocetine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, RA; Manallack, DT; Thompson, PE | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Akopov, SE; Gabrielian, ES | 1 |
| Kiss, B; Milusheva, E; Papasova, M; Pásztor, E; Sperlágh, B; Szporny, L; Vizi, ES | 1 |
| Akopov, SE; Balaian, BG; Gabrielian, ES | 1 |
| Vinichuk, SM | 1 |
| Malyĭ, VD; Vinichuk, SM | 1 |
| Eninia, GI; Purinia, IV; Timofeeva, TN | 1 |
| Saeki, T; Saito, I | 1 |
| Cheng, JB; Cohan, VL; Eskra, JD; Griffiths, RJ; Pazoles, CJ; Pettipher, ER; Showell, HJ; Turner, CR; Watson, JW | 1 |
| Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M | 1 |
| Baba, A; Enomoto, R; Lee, E; Matsuda, T; Mori, K; Takuma, K | 1 |
| Brading, AF; Jones, OM; McC Mortensen, NJ | 1 |
| Bickle, M; Chakroun, T; Chiu, WH; Goebel, JN; Höglinger, GU; Höllerhage, M; Koeglsperger, T; Melms, J; Moebius, C; Oertel, WH; Rösler, TW | 1 |
1 review(s) available for dipyridamole and vinpocetine
| Article | Year |
|---|---|
The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP; Cyclic GMP; Drug Design; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Quantitative Structure-Activity Relationship; Xanthines | 2005 |
1 trial(s) available for dipyridamole and vinpocetine
| Article | Year |
|---|---|
Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
Topics: Adenosine Diphosphate; Arteriosclerosis; Aspirin; Collagen; Dipyridamole; Double-Blind Method; Epinephrine; Humans; In Vitro Techniques; Middle Aged; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Vinca Alkaloids | 1992 |
14 other study(ies) available for dipyridamole and vinpocetine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Inhibitory effect of hypoxic condition on acetylcholine release is partly due to the effect of adenosine released from the tissue.
Topics: Acetylcholine; Adenosine; Animals; Dipyridamole; Female; Guinea Pigs; Hypoxia; In Vitro Techniques; Male; Muscles; Vinca Alkaloids | 1990 |
[Effect of prostacyclin on the cerebral vessels and its pharmacological modification].
Topics: Cadaver; Cerebral Arteries; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Humans; Intracranial Arteriosclerosis; Nifedipine; Vasodilation; Vinca Alkaloids | 1986 |
[Effect of corglycon and vasoactive agents on systemic and cerebral hemodynamics in cerebral infarct].
Topics: Aged; Cerebral Infarction; Cerebrovascular Circulation; Dipyridamole; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Strophanthins; Vasodilator Agents; Vinca Alkaloids | 1987 |
[Hemodynamic disorders and various problems in treatment in strokes with reversible neurologic deficits].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Bencyclane; Brain Ischemia; Dipyridamole; Diuretics; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1986 |
[The effect of kavinton, trental, sermion and kurantil on the blood flow rate in individual segments of the cerebral arteries].
Topics: Blood Flow Velocity; Cerebral Arteries; Chronic Disease; Dipyridamole; Drug Evaluation; Female; Humans; Injections, Intravenous; Intracranial Arteriosclerosis; Male; Middle Aged; Myocardial Ischemia; Nicergoline; Pentoxifylline; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 1994 |
Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta.
Topics: Animals; Aorta; Calmodulin; Chromatography, Affinity; Cyclic AMP; Cyclic GMP; Dipyridamole; Isoenzymes; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Swine; Vinca Alkaloids | 1993 |
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenalectomy; Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dipyridamole; Epinephrine; Humans; Kinetics; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Monocytes; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piroxicam; Propranolol; Purinones; Pyrimidinones; Thromboxane B2; Time Factors; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 1997 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines | 1999 |
Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model.
Topics: Alkaloids; Animals; Animals, Newborn; Apoptosis; Astrocytes; Carbazoles; Cell Survival; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytochrome c Group; Dipyridamole; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Indoles; Mitochondria; Pentoxifylline; Peptide Hydrolases; Phosphodiesterase Inhibitors; Purinones; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Theophylline; Vinca Alkaloids | 2001 |
Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro.
Topics: Adenine; Aged; Aged, 80 and over; Anal Canal; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Isoquinolines; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Purinones; Rectum; Rolipram; Tetrahydroisoquinolines; Vinca Alkaloids | 2002 |
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells.
Topics: alpha-Synuclein; Animals; Cell Line; Dipyridamole; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Mice; Neurons; Neuroprotective Agents; Phosphodiesterase I; Protein Aggregation, Pathological; Vinca Alkaloids | 2017 |